Sanofi-Aventis (France) May Cut EU1 Billion in Costs, Buy Biotechs

Feb. 10 (Bloomberg) -- Sanofi-Aventis SA Chief Executive Officer Chris Viehbacher may outline plans to cut as much as 1 billion euros ($1.3 billion) in costs and buy smaller companies after the failure of its most-promising medicine.